Academic Highlights: Managing ADHD in Children, Adolescents, and Adults With Comorbid Anxiety. [CME]
J Clin Psychiatry 2007;68:451-462
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Attention-deficit/hyperactivity disorder (ADHD) is a relatively common disorder, estimated to affect 3% to 6% of children1 and 4.5% of adults.2 Individuals with ADHD, their families, and society as a whole bear the burden of this disorder, even though effective pharmacologic and psychosocial treatments are available. Annual direct medical costs for children with ADHD have been found to be approximately 50% to 75% more than those of children without ADHD,3,4 and family members of patients with ADHD have direct and indirect costs that are almost double those of family members of children without ADHD.4